Cargando…

Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study

Purpose: Although clinicians encounter patients aged ≥70 years with locally advanced oral cavity squamous cell carcinoma (LA-OCSCC), no evidence is available to facilitate decision making regarding treatment for this elderly population. Methods: We selected elderly (≥70 years) patients from the Taiw...

Descripción completa

Detalles Bibliográficos
Autores principales: Shia, Ben-Chang, Qin, Lei, Lin, Kuan-Chou, Fang, Chih-Yuan, Tsai, Lo-Lin, Kao, Yi-Wei, Wu, Szu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072345/
https://www.ncbi.nlm.nih.gov/pubmed/31973016
http://dx.doi.org/10.3390/cancers12020258
_version_ 1783506384949608448
author Shia, Ben-Chang
Qin, Lei
Lin, Kuan-Chou
Fang, Chih-Yuan
Tsai, Lo-Lin
Kao, Yi-Wei
Wu, Szu-Yuan
author_facet Shia, Ben-Chang
Qin, Lei
Lin, Kuan-Chou
Fang, Chih-Yuan
Tsai, Lo-Lin
Kao, Yi-Wei
Wu, Szu-Yuan
author_sort Shia, Ben-Chang
collection PubMed
description Purpose: Although clinicians encounter patients aged ≥70 years with locally advanced oral cavity squamous cell carcinoma (LA-OCSCC), no evidence is available to facilitate decision making regarding treatment for this elderly population. Methods: We selected elderly (≥70 years) patients from the Taiwan Cancer Registry database who had received a diagnosis of LA-OCSCC. Propensity score matching was performed. Cox proportional hazards model curves were used to analyze all-cause mortality in patients in different age groups receiving different treatments. Results: The matching process yielded a final cohort of 976 patients in concurrent chemoradiotherapy (CCRT), non-treatment, radiotherapy (RT) alone, and surgery cohorts who were eligible for further analysis. After stratified analysis, the adjusted hazard ratios (aHRs) (95% confidence intervals [CIs]) derived for surgery, RT alone, and non-treatment compared with CCRT were 0.66 (0.52 to 0.83), 1.02 (0.81 to 1.28), and 1.52 (1.21 to 1.91), respectively, in patients aged 70 to 80 years. In the oldest patients (aged >80 years), multivariate analysis indicated that the results of surgery or RT alone were nonsignificant compared with those of CCRT. The aHR (95% CI) derived for the highest mortality was 1.81 (1.11 to 2.40) for non-treatment compared with CCRT. Conclusions: Surgery for elderly patients with LA-OCSCC is associated with a significant survival benefit, but the association is nonsignificant in the oldest elderly patients. No survival differences were observed between RT alone and CCRT in these elderly patients. Non-treatment should not be an option for these patients.
format Online
Article
Text
id pubmed-7072345
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70723452020-03-19 Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study Shia, Ben-Chang Qin, Lei Lin, Kuan-Chou Fang, Chih-Yuan Tsai, Lo-Lin Kao, Yi-Wei Wu, Szu-Yuan Cancers (Basel) Article Purpose: Although clinicians encounter patients aged ≥70 years with locally advanced oral cavity squamous cell carcinoma (LA-OCSCC), no evidence is available to facilitate decision making regarding treatment for this elderly population. Methods: We selected elderly (≥70 years) patients from the Taiwan Cancer Registry database who had received a diagnosis of LA-OCSCC. Propensity score matching was performed. Cox proportional hazards model curves were used to analyze all-cause mortality in patients in different age groups receiving different treatments. Results: The matching process yielded a final cohort of 976 patients in concurrent chemoradiotherapy (CCRT), non-treatment, radiotherapy (RT) alone, and surgery cohorts who were eligible for further analysis. After stratified analysis, the adjusted hazard ratios (aHRs) (95% confidence intervals [CIs]) derived for surgery, RT alone, and non-treatment compared with CCRT were 0.66 (0.52 to 0.83), 1.02 (0.81 to 1.28), and 1.52 (1.21 to 1.91), respectively, in patients aged 70 to 80 years. In the oldest patients (aged >80 years), multivariate analysis indicated that the results of surgery or RT alone were nonsignificant compared with those of CCRT. The aHR (95% CI) derived for the highest mortality was 1.81 (1.11 to 2.40) for non-treatment compared with CCRT. Conclusions: Surgery for elderly patients with LA-OCSCC is associated with a significant survival benefit, but the association is nonsignificant in the oldest elderly patients. No survival differences were observed between RT alone and CCRT in these elderly patients. Non-treatment should not be an option for these patients. MDPI 2020-01-21 /pmc/articles/PMC7072345/ /pubmed/31973016 http://dx.doi.org/10.3390/cancers12020258 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shia, Ben-Chang
Qin, Lei
Lin, Kuan-Chou
Fang, Chih-Yuan
Tsai, Lo-Lin
Kao, Yi-Wei
Wu, Szu-Yuan
Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title_full Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title_fullStr Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title_full_unstemmed Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title_short Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
title_sort outcomes for elderly patients aged 70 to 80 years or older with locally advanced oral cavity squamous cell carcinoma: a propensity score–matched, nationwide, oldest old patient–based cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072345/
https://www.ncbi.nlm.nih.gov/pubmed/31973016
http://dx.doi.org/10.3390/cancers12020258
work_keys_str_mv AT shiabenchang outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT qinlei outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT linkuanchou outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT fangchihyuan outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT tsailolin outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT kaoyiwei outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy
AT wuszuyuan outcomesforelderlypatientsaged70to80yearsorolderwithlocallyadvancedoralcavitysquamouscellcarcinomaapropensityscorematchednationwideoldestoldpatientbasedcohortstudy